1fbz

From Proteopedia

proteopedia linkproteopedia link

spinqualitylabelsall models 1fbz, resolution 2.40Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo anti-resorptive activity

Contents 1 Overview 2 Disease 3 About this Structure 4 Reference

Overview

Targeted disruption of the pp60(src) (Src) gene has implicated this, tyrosine kinase in osteoclast-mediated bone resorption and as a, therapeutic target for the treatment of osteoporosis and other, bone-related diseases. Herein we describe the discovery of a nonpeptide, inhibitor (AP22408) of Src that demonstrates in vivo antiresorptive, activity. Based on a cocrystal structure of the noncatalytic Src homology, 2 (SH2) domain of Src complexed with citrate [in the phosphotyrosine, (pTyr) binding pocket], we designed 3',4'-diphosphonophenylalanine (Dpp), as a pTyr mimic. In addition to its design to bind Src SH2, the Dpp moiety, exhibits bone-targeting properties that confer osteoclast selectivity, hence minimizing possible undesired effects on other cells that have, Src-dependent activities. The chemical structure AP22408 also illustrates, a bicyclic template to replace the post-pTyr sequence of cognate Src SH2, phosphopeptides such as Ac-pTyr-Glu-Glu-Ile (1). An x-ray structure of, AP22408 complexed with Lck (S164C) SH2 confirmed molecular interactions of, both the Dpp and bicyclic template of AP22408 as predicted from molecular, modeling. Relative to the cognate phosphopeptide, AP22408 exhibits, significantly increased Src SH2 binding affinity (IC(50) = 0.30 microM for, AP22408 and 5.5 microM for 1). Furthermore, AP22408 inhibits rabbit, osteoclast-mediated resorption of dentine in a cellular assay, exhibits, bone-targeting properties based on a hydroxyapatite adsorption assay, and, demonstrates in vivo antiresorptive activity in a parathyroid, hormone-induced rat model.

Disease

Known disease associated with this structure: SCID due to LCK deficiency OMIM:[153390]

About this Structure

1FBZ is a Single protein structure of sequence from Homo sapiens with CC1 as ligand. Active as Transferase, with EC number and 2.7.10.2 2.7.10.1 and 2.7.10.2 Full crystallographic information is available from OCA.

Reference

Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity., Shakespeare W, Yang M, Bohacek R, Cerasoli F, Stebbins K, Sundaramoorthi R, Azimioara M, Vu C, Pradeepan S, Metcalf C 3rd, Haraldson C, Merry T, Dalgarno D, Narula S, Hatada M, Lu X, van Schravendijk MR, Adams S, Violette S, Smith J, Guan W, Bartlett C, Herson J, Iuliucci J, Weigele M, Sawyer T, Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9373-8. PMID:10944210

Page seeded by OCA on Mon Nov 12 16:51:15 2007